Details for New Drug Application (NDA): 085122
✉ Email this page to a colleague
NDA 085122 describes TRIAMCINOLONE DIACETATE, which is a drug marketed by Epic Pharma Llc and Watson Labs and is included in four NDAs. Additional details are available on the TRIAMCINOLONE DIACETATE profile page.
The generic ingredient in TRIAMCINOLONE DIACETATE is triamcinolone diacetate. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone diacetate profile page.
The generic ingredient in TRIAMCINOLONE DIACETATE is triamcinolone diacetate. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone diacetate profile page.
Summary for 085122
| Tradename: | TRIAMCINOLONE DIACETATE |
| Applicant: | Epic Pharma Llc |
| Ingredient: | triamcinolone diacetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
